European Migraine Webinar Series 2020 - Header Image


11.02.2021 - 11.02.2021 Addressing Migraine and its Comorbidities

Migraine is the second most disabling condition globally, and comorbidities and co-occurring conditions contribute to the overall disease burden.1 Identified comorbidities associated with migraine include cardiovascular disorders (i.e. stroke, myocardial infarction), psychiatric disorders (e.g. depression, anxiety, panic disorder), neurologic disease and sleep conditions among others.1 In one study including 15,133 people with migraine, increasing headache pain intensity was associated with comorbid inflammation, psychiatric disorders and sleep conditions.1 

In this webinar, Professor Messoud Ashina from the University of Copenhagen, Denmark presents three clinical cases that showcase the impact of migraine and its comorbidities. Clinical data supporting the use of monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway will be discussed for individuals with migraine and comorbid depression, and for older individuals with migraine.

If you missed the live broadcast, follow the link and you can watch Prof. Messoud Ashina’s webinar on-demand.

  1. Buse DC, Reed ML, Fanning KM, et al. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain 2020;21:23.